Alert: Hydroxycut Lawsuits Have Already Been Reported
On May 1, 2009, there had been a recall of fourteen Hydroxycut diet-aid products stemming from a number of reports that folks using the products were developing heavy liver issues and other health worries. Less than seven days later, on May 4, the 1st Hydroxycut class action suit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Settlements alleges company neglectfulness in informing the public about potential hazards of the products. Naturally, it’s too soon to understand the suit is going to turn out, but if the company had information which it didn’t divulge to customers, it should definitely be held accountable.
A class action court action is filed by a bunch of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and far less dear, than filing an individual suit. As a rule, filing a class action legal action will not cost anything unless there is a settlement. At that time, the lawyer who handled the suit will take his costs from the compensation that was awarded and then share the leftover funds to the accusers in the case. Since this is the case, you will be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is an example of the reasons that class action lawsuits have become so popular.
The first class action suit against Iovate was filed in Canada where the company is located and represents all Canadian voters who sustained health problems due to Hydroxycut products. The FDA recall took place in the U. S. where 23 cases of liver disorders and other health problems had been reported. Health Canada did not receive any reports of liver damage due to the diet products, but they did receive 17 reports concerning folks who sustained respiratory, neurological, cardiovascular, and gut issues as a consequence of Canadians using the products.
The Hydroxycut Lawsuits alleges that the products without correctly informing the products without properly informing the public of the health risks that they could exposing buyers to. The complaint states the company failed to publish the data on the product labels saying that users could run the chance of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological issues. The suit goes on to allege that this was an obvious omission on the part of the company which purposely misled buyers concerning the protection of the products.
